Aveo Pharmaceuticals is a leading biopharmaceutical company based in Cambridge, MA, dedicated to passionately pursuing a better life for patients with cancer. With a strong focus on research and development, Aveo Pharmaceuticals offers a diverse pipeline of innovative oncology products, including Tivozanib, Ficlatuzumab, AV-203, AV-380, and AV-353.
Committed to advancing cancer treatment, Aveo Pharmaceuticals conducts extensive medical research, publishes scientific publications, and presents at prestigious conferences. The company also provides medical grants and supports expanded access policies to ensure patients have access to their life-saving medications. With a dedicated team and strategic partnerships, Aveo Pharmaceuticals continues to make significant contributions to the field of oncology.
Generated from the website